Financial Hardship in Childhood Cancer Survivors Treated with Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study
- PMID: 37541329
- PMCID: PMC10834839
- DOI: 10.1016/j.jtct.2023.07.024
Financial Hardship in Childhood Cancer Survivors Treated with Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study
Abstract
Long-term survivors of childhood cancer are at risk for financial hardship. However, it is not known if HCT leads to an incremental change in financial hardship for survivors who received it versus those who did not. We examined financial outcomes among adult survivors of childhood cancer who had undergone HCT. Using a cross-sectional survey in the Childhood Cancer Survivor Study population between 2017 and 2019, self-reported financial hardship was compared between survivors who received HCT, survivors treated without HCT ("non-HCT"), and siblings and categorized into 3 domains: material hardship/financial sacrifices, behavioral, and psychological hardship. The standardized score of each domain of financial hardship was calculated by adding the item responses and dividing by the standard deviation among siblings. Multivariable linear and logistic regression were used to evaluate associations between sociodemographic characteristics, cancer diagnosis, post-treatment complications, and financial hardship among survivors. The mean adjusted score for each hardship domain was not significantly different between HCT survivors (n = 133) and non-HCT survivors (n = 2711); mean differences were .18 (95% confidence interval [CI], -.05 to .41) for material hardship/financial sacrifices, .07 (95% CI, -.18 to .32) for behavioral hardship, and .19 (95% CI, -.04 to .42) for psychological hardship. Within specific items, a higher proportion of survivors treated with HCT reported greater financial hardship compared to non-HCT survivors. HCT survivors also had significantly higher mean domain scores compared to sibling controls (n = 1027) in all domains. Household income and chronic health conditions, but not HCT, were associated with financial hardship among all survivors. Adult survivors of childhood cancer treated with HCT do not report greater overall financial hardship compared to non-HCT survivors but do report greater overall financial hardship compared to sibling controls. Surveillance and intervention may be necessary for all survivors regardless of HCT status.
Keywords: Childhood cancer survivor; Financial hardship; Hematopoietic cell transplantation.
Copyright © 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study report.Cancer. 2024 Apr 1;130(7):1125-1136. doi: 10.1002/cncr.35150. Epub 2023 Dec 15. Cancer. 2024. PMID: 38100563 Free PMC article.
-
Financial Hardship in Adult Survivors of Childhood Cancer in the Era After Implementation of the Affordable Care Act: A Report From the Childhood Cancer Survivor Study.J Clin Oncol. 2023 Feb 10;41(5):1000-1010. doi: 10.1200/JCO.22.00572. Epub 2022 Sep 30. J Clin Oncol. 2023. PMID: 36179267 Free PMC article.
-
Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study.Cancer. 2021 Sep 1;127(17):3214-3222. doi: 10.1002/cncr.33613. Epub 2021 Jun 1. Cancer. 2021. PMID: 34061973 Free PMC article.
-
Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Biol Blood Marrow Transplant. 2016 May;22(5):782-95. doi: 10.1016/j.bbmt.2016.01.023. Epub 2016 Jan 21. Biol Blood Marrow Transplant. 2016. PMID: 26802323 Free PMC article. Review.
-
Financial Hardship and the Economic Effect of Childhood Cancer Survivorship.J Clin Oncol. 2018 Jul 20;36(21):2198-2205. doi: 10.1200/JCO.2017.76.4431. Epub 2018 Jun 6. J Clin Oncol. 2018. PMID: 29874136 Review.
Cited by
-
Challenges and Opportunities in the Care of Hematopoietic Cell Transplant Survivors in the Modern Era.Adv Exp Med Biol. 2025;1475:209-226. doi: 10.1007/978-3-031-84988-6_12. Adv Exp Med Biol. 2025. PMID: 40488832 Review.
-
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.Transplant Cell Ther. 2025 Apr;31(4):224.e1-224.e13. doi: 10.1016/j.jtct.2024.12.019. Epub 2024 Dec 27. Transplant Cell Ther. 2025. PMID: 39733839
-
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.Blood Adv. 2024 Oct 8;8(19):5146-5155. doi: 10.1182/bloodadvances.2024012998. Blood Adv. 2024. PMID: 39146495 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical